185 related articles for article (PubMed ID: 2958498)
1. Quality control limits for teicoplanin susceptibility tests and confirmation of disk diffusion interpretive criteria.
Barry AL; Jones RN; Gavan TL; Thornsberry C
J Clin Microbiol; 1987 Sep; 25(9):1812-4. PubMed ID: 2958498
[TBL] [Abstract][Full Text] [Related]
2. Diffusion of teicoplanin and vancomycin in agar.
Cavenaghi LA; Biganzoli E; Danese A; Parenti F
Diagn Microbiol Infect Dis; 1992; 15(3):253-8. PubMed ID: 1533826
[TBL] [Abstract][Full Text] [Related]
3. Ofloxacin susceptibility testing quality control parameters for microdilution and disk diffusion, and confirmation of disk diffusion interpretive criteria.
Fuchs PC; Jones RN; Barry AL; Gavan TL
J Clin Microbiol; 1989 Jan; 27(1):49-52. PubMed ID: 2492304
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of teicoplanin and vancomycin against gram-positive bacteria from human clinical and veterinary sources.
Jensen KT; Schønheyder H; Pers C; Thomsen VF
APMIS; 1992 Jun; 100(6):543-52. PubMed ID: 1535201
[TBL] [Abstract][Full Text] [Related]
5. Proficiency of Italian clinical laboratories in detecting reduced glycopeptide susceptibility in Enterococcus and Staphylococcus spp. using routine laboratory methodologies.
Jones ME; Gesu G; Ortisi G; Sahm DF; Critchley IA; Goglio A;
Clin Microbiol Infect; 2002 Feb; 8(2):101-11. PubMed ID: 11952723
[TBL] [Abstract][Full Text] [Related]
6. Activities of daptomycin and teicoplanin against Staphylococcus haemolyticus and Staphylococcus epidermidis, including evaluation of susceptibility testing recommendations.
Low DE; McGeer A; Poon R
Antimicrob Agents Chemother; 1989 Apr; 33(4):585-8. PubMed ID: 2543286
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of Staphylococcus species and subspecies to teicoplanin.
Bannerman TL; Wadiak DL; Kloos WE
Antimicrob Agents Chemother; 1991 Sep; 35(9):1919-22. PubMed ID: 1835340
[TBL] [Abstract][Full Text] [Related]
8. [In vitro activity of vancomycin and teicoplanin against gram-positive cocci].
Bezian MC; Ribou G; Masquelier B
Pathol Biol (Paris); 1992 May; 40(5):461-5. PubMed ID: 1386667
[TBL] [Abstract][Full Text] [Related]
9. The prevalence of staphylococcal resistance to penicillinase-resistant penicillins. A retrospective and prospective national surveillance trial of isolates from 40 medical centers.
Jones RN; Barry AL; Gardiner RV; Packer RR
Diagn Microbiol Infect Dis; 1989; 12(5):385-94. PubMed ID: 2533050
[TBL] [Abstract][Full Text] [Related]
10. Quality control parameters and interpretive criteria for in vitro susceptibility tests with the macrolide azithromycin. Collaborative Antimicrobial Susceptibility Testing Group.
Barry AL; Thornsberry C; Gavan TL
Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):544-9. PubMed ID: 2548865
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Staphylococcus aureus and coagulase-negative staphylococci with decreased sensitivity to glycopeptides as assessed by determination of MICs.
Vedel G; Leruez M; Lémann F; Hraoui E; Ratovohery D
Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):820-2. PubMed ID: 2150815
[TBL] [Abstract][Full Text] [Related]
12. European Glycopeptide Susceptibility Survey of gram-positive bacteria for 1995. European Glycopeptide Resistance Survey Study Group.
Felmingham D; Brown DF; Soussy CJ
Diagn Microbiol Infect Dis; 1998 Aug; 31(4):563-71. PubMed ID: 9764397
[TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis.
Sahm DF; Kissinger J; Gilmore MS; Murray PR; Mulder R; Solliday J; Clarke B
Antimicrob Agents Chemother; 1989 Sep; 33(9):1588-91. PubMed ID: 2554802
[TBL] [Abstract][Full Text] [Related]
14. Daptomycin susceptibility tests: interpretive criteria, quality control, and effect of calcium on in vitro tests.
Fuchs PC; Barry AL; Brown SD
Diagn Microbiol Infect Dis; 2000 Sep; 38(1):51-8. PubMed ID: 11025184
[TBL] [Abstract][Full Text] [Related]
15. Quality control of susceptibility tests with 5-micrograms trimethoprim disks.
Barry AL; Jones RN; Gavan TL
J Clin Microbiol; 1984 Oct; 20(4):817-9. PubMed ID: 6436317
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the agar dilution, tube dilution, and broth microdilution susceptibility tests for determination of teicoplanin MICs.
Kenny MT; Dulworth JK; Brackman MA
J Clin Microbiol; 1989 Jun; 27(6):1409-10. PubMed ID: 2526821
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization and multilaboratory evaluation of Enterococcus faecalis ATCC 51299 for quality control of screening tests for vancomycin and high-level aminoglycoside resistance in enterococci.
Swenson JM; Clark NC; Sahm DF; Ferraro MJ; Doern G; Hindler J; Jorgensen JH; Pfaller MA; Reller LB; Weinstein MP
J Clin Microbiol; 1995 Nov; 33(11):3019-21. PubMed ID: 8576364
[TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of a European collaborative study on comparative susceptibility of gram-positive clinical isolates to teicoplanin and vancomycin.
Grüneberg RN; Hryniewicz W
Int J Antimicrob Agents; 1998 Nov; 10(4):271-7. PubMed ID: 9916900
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial susceptibility of coagulase-negative staphylococci and characterization of isolates with reduced susceptibility to glycopeptides.
Del' Alamo L; Cereda RF; Tosin I; Miranda EA; Sader HS
Diagn Microbiol Infect Dis; 1999 Jul; 34(3):185-91. PubMed ID: 10403098
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of teicoplanin and vancomycin disk susceptibility tests.
Barry AL; Thornsberry C; Jones RN
J Clin Microbiol; 1986 Jan; 23(1):100-3. PubMed ID: 2939101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
